Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System

A trial with no phase registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 399 participants.

Also called NCT01187368

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 399 participants (planned count) (from the registry)
Sponsor
Evaheart, Inc. (from the registry)
Registry
  • NCT NCT01187368
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Suspended (from the registry)

Technical summary

Registry record NCT01187368. Randomized; no masking; primary purpose treatment. Start 2020-03-31 (actual); primary completion 2027-07-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System
Acronym
COMPETENCE
Condition
Heart Failure
Intervention (Device)
EVAHEART Left Ventricular Assist System (LVAS)
Intervention (Device)
HeartMate 3
Lead sponsor
Evaheart, Inc. (class: industry)

Record details

Record id
cardio:ct-nct01187368
Content hash
9fd3acebc5fc22e5f777fa7b83d8468aedae6f134d6f42328d948613923d1e7b